Skip to Main Content

Paper Details

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
J Clin Oncol
115
2019
BC, CDK4/6, ER, ER-positive BC, Estrogen, Estrogen Receptor, Estrogen Receptor-Positive Early Breast Cancer, Ki-67, Letrozole, MKI67 gene, PATIENTS, Palbociclib, estrogen, estrogen receptor, letrozole, malignant cell, metastatic breast cancer, palbociclib, patients, poly (ADP-ribose), poly (ADP-ribose) polymerase, tumors, women
Author NameAffiliation
Mothaffar F Rimawi8 Baylor College of Medicine
Robert C Stein11 National Institute for Health Research University College London Hospitals Biomedical Research Centre
Robert C Stein12 University College London Hospitals National Health Service Foundation Trust
Charles Kent Osborne8 Baylor College of Medicine
  • 1 - 4

Datasets

Release 1.2